Active Pharmaceutical Ingredients Market in North America
North American Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020 This report provides in-depth analysis of the North American active pharmaceutical ingredients (API) market and presents revenue forecasts up to 2020 for the United States and Canada. The report is based around the two major product types, namely, synthetic API and biotech API. Revenue forecasts are provided for both the product types. The synthetic API market is further analyzed based on the customer base – generic and innovative sectors. This study also provides detailed insights into the factors affecting the dynamics of the market with strategic analysis of the major trends. Market share analysis of the major companies in the whole North American market is also covered in the report. ( http://www.bharatbook.com/Market-Research-Reports/North-America-Active-Pharmaceutical-Ingredients-Market-Analysis-and-Forecasts-to-2020.html ) Economic Crisis Slows the Revenue Growth of the North American API Market The current global economic crisis has negatively affected the North American API market leading to a drastic reduction in its growth. The economic crisis has necessitated the need for the governments to reduce their expenditure even in the healthcare sector. Therefore, in an attempt to realize significant savings of the healthcare expenditure, there is a shift away from the high-priced innovative drugs in the United States and Canada. This has resulted in a significant slowdown in the revenue growth of the North American API market. In 2009, the North American API market is set grow at a rate of around 2%. Biotech APIs Set to Drive the Overall Growth of the API Market in North America The biotech API market in North America is geared for a higher growth which is set to drive the overall growth of the API market. The increasing demand for the biological drugs is boosting the demand for the biotech API in the market place. Also, the technological advancement in the pharmaceutical industry is paving way for newer biotechnology drugs. The pharmaceutical industry is also optimistic about the approval of biogeneric drugs which is expected to create further growth in the development of the biotech API market. This will boost the growth of the biotech API market making it to grow at a rate significantly higher than the synthetic API market. The biotech API market is expected to grow at a CAGR of around 13% from 2008 to 2020. Generic APIs Get a Boost Due to the Cost-Containment Measures in North America Canada Poised to Increase its Revenue Share in the North American API Market The Canadian API market, which held a revenue share of around 6% in 2008, is bound to increase its share to 7% in 2015. The Canadian API market is characterized by an emerging biotech API product segment which is growing fastest in the North American market. Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com
Powered By Rxid.com